Amrize (NYSE:AMRZ – Get Free Report) was upgraded by equities research analysts at Kepler Capital Markets to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.
Other analysts have also recently issued reports about the stock. UBS Group lifted their target price on shares of Amrize from $49.00 to $52.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 14th. Zacks Research raised shares of Amrize from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Royal Bank Of Canada lowered their target price on shares of Amrize from $61.00 to $54.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Wells Fargo & Company raised shares of Amrize to a “strong-buy” rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amrize in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $57.50.
Read Our Latest Stock Report on AMRZ
Amrize Price Performance
Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25). The firm had revenue of $3.22 billion for the quarter.
Insider Activity at Amrize
In related news, CTO Roald Brouwer acquired 2,000 shares of the stock in a transaction dated Wednesday, August 27th. The stock was bought at an average cost of $51.88 per share, with a total value of $103,760.00. Following the purchase, the chief technology officer directly owned 5,000 shares of the company’s stock, valued at approximately $259,400. This represents a 66.67% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jan Philipp Jenisch acquired 50,000 shares of the stock in a transaction dated Monday, August 11th. The shares were bought at an average cost of $47.50 per share, with a total value of $2,375,000.00. Following the completion of the purchase, the chief executive officer directly owned 450,000 shares in the company, valued at approximately $21,375,000. This trade represents a 12.50% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders bought 1,124,000 shares of company stock worth $53,225,260.
Institutional Trading of Amrize
Institutional investors have recently made changes to their positions in the stock. Global Retirement Partners LLC purchased a new stake in shares of Amrize during the 3rd quarter valued at $48,000. BNP Paribas Financial Markets purchased a new stake in shares of Amrize during the 2nd quarter valued at $59,000. Groupe la Francaise purchased a new stake in shares of Amrize during the 2nd quarter valued at $60,000. Allianz SE purchased a new stake in shares of Amrize during the 2nd quarter valued at $80,000. Finally, Osaic Holdings Inc. acquired a new position in shares of Amrize during the 2nd quarter valued at $90,000.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Stories
- Five stocks we like better than Amrize
- Are Penny Stocks a Good Fit for Your Portfolio?
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Best Stocks Under $5.00
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- Asset Allocation Strategies in Volatile Markets
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.